These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7535946)

  • 1. Interactions in vitro and in vivo between porcine tissue kallikrein and porcine plasma proteinase inhibitors.
    Bläckberg M; Ohlsson K
    Scand J Clin Lab Invest; 1994 Dec; 54(8):643-51. PubMed ID: 7535946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human tissue kallikrein by alpha 1-proteinase inhibitor.
    Hirano K; Okumura Y; Hayakawa S; Adachi T; Sugiura M
    Hoppe Seylers Z Physiol Chem; 1984 Jan; 365(1):27-32. PubMed ID: 6201429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the release of tissue kallikrein in experimental pancreatitis in the pig.
    Bläckberg M; Ohlsson K
    Eur Surg Res; 1994; 26(2):116-24. PubMed ID: 8005167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC
    J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.
    Schapira M; Scott CF; Colman RW
    J Clin Invest; 1982 Feb; 69(2):462-8. PubMed ID: 6173399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between clearance rates of plasma kallikrein and of plasma kallikrein-alpha-macroglobulin complexes by the liver.
    Ogata H; Kouyoumdjian M; Borges DR
    Int J Biochem; 1993 Jul; 25(7):1047-51. PubMed ID: 7689988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
    Harpel PC
    J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new tissue-kallikrein-binding protein.
    Chao J; Tillman DM; Wang MY; Margolius HS; Chao L
    Biochem J; 1986 Oct; 239(2):325-31. PubMed ID: 3643793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of rat tissue kallikrein gene family members by rat kallikrein-binding protein and alpha 1-proteinase inhibitor.
    Serveau C; Moreau T; Zhou GX; ElMoujahed A; Chao J; Gauthier F
    FEBS Lett; 1992 Sep; 309(3):405-8. PubMed ID: 1445595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive inhibition of human glandular (urinary) kallikrein by human serum and identification of the progressive antikallikrein as alpha 1-antitrypsin (alpha 1-protease inhibitor).
    Geiger R; Stuckstedte U; Clausnitzer B; Fritz H
    Hoppe Seylers Z Physiol Chem; 1981 Mar; 362(3):317-25. PubMed ID: 6971794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikrein inhibitors in rat plasma.
    Hojima Y; Isobe M; Moriya H
    J Biochem; 1977 Jan; 81(1):37-46. PubMed ID: 14935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of enzymatically active kallikrein hK2 from human seminal plasma.
    Frenette G; Deperthes D; Tremblay RR; Lazure C; Dubé JY
    Biochim Biophys Acta; 1997 Feb; 1334(1):109-15. PubMed ID: 9042371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human plasma kallikrein and its light chain with alpha 2-macroglobulin.
    van der Graaf F; Rietveld A; Keus FJ; Bouma BN
    Biochemistry; 1984 Apr; 23(8):1760-6. PubMed ID: 6202319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.
    Sulikowski T; Bauer BA; Patston PA
    Protein Sci; 2002 Sep; 11(9):2230-6. PubMed ID: 12192078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on plasma inhibitors of plasma kallikrein using chromogenic peptide substrate assays.
    Gallimore MJ; Amundsen E; Larsbraaten M; Lyngaas K; Fareid E
    Thromb Res; 1979; 16(5-6):695-703. PubMed ID: 93313
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo metabolism of inter-alpha-trypsin inhibitor and its proteinase complexes: evidence for proteinase transfer to alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Pratt CW; Pizzo SV
    Arch Biochem Biophys; 1986 Aug; 248(2):587-96. PubMed ID: 2427028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnover of 125I-labelled tissue kallikrein following intraduodenal or intravenous administration.
    Bläckberg M; Ohlsson K
    Scand J Clin Lab Invest; 2001 Feb; 61(1):57-67. PubMed ID: 11300612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance and metabolism of glandular kallikrein in the rat.
    Rabito SF; Seto M; Maitra SR; Carretero OA
    Am J Physiol; 1985 Jun; 248(6 Pt 1):E664-8. PubMed ID: 3847263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kallikrein-specific inhibitor in rat kidney tubules.
    Geiger R; Mann K
    Hoppe Seylers Z Physiol Chem; 1976 Apr; 357(4):553-8. PubMed ID: 9350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.